Обзор рекомендаций Американского общества по инфекционным заболеваниям по ведению пациентов с инфекциями диабетической стопы

Клиническая Микробиология и Антимикробная Химиотерапия. 2013; 15(1):14-22

​ Привольнев В.В., Гусева Е.А., Каракулина Е.В.
диабетическая стопа инфекции рекомендации
Раздел
Болезни и возбудители
Тип
Журнальная статья
Публикация
Клиническая Микробиология и Антимикробная Химиотерапия. 2013; 15(1):14-22

Аннотация

Инфекционные осложнения при синдроме диабетической стопы остаются значимой медицинской, социальной и экономической проблемой. И, по­прежнему, результатом этих осложнений является высокий риск ампутации конечности. В данной публикации рассматриваются клиническая диагностика инфекции диабетической стопы, сложные вопросы диагностики остеомиелита, вопросы амбулаторного и стационарного лечения пациентов, ответственности различных специалистов за результат лечения пациента, представленные в рекомендациях Американского общества по инфекционным заболеваниям (IDSA) пересмотра 2012 года. Рекомендации сравниваются с предыдущей версией от 2007 года и с ситуацией, реально существующей в нашей стране.

  • 1. Aragon-Sanchez J. Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds 2011; 10:33-65.
  • 2. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55.
  • 3. Tan T., Shaw E.J., Siddiqui F., Kandaswamy P., BarryP.W., Baker M. Inpatient management of diabetic foot problems: summary of NICE guidance. BMJ 2011; 342:d1280.
  • 4. Fisher T.K., Wolcott R., Wolk D.M., Bharara M., Kimbriel H.R., Armstrong D.G. Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds 2010; 9:31-6.
  • 5. Lipsky B.A., Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 2009; 49:1541-9.
  • 6. Richard J.L., Lavigne J.P., Got I., et al. Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study. Diabetes Metab 2010; 37:208-15.
  • 7. Vedhara K., Miles J.N., Wetherell M.A., et al. Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence. Diabetologia 2010; 53:1590-8.
  • 8. Akinci B., Yener S., Yesil S., Yapar N., Kucukyavas Y., Bayraktar F. Acute phase reactants predict the risk of amputation in diabetic foot infection. J Am Podiatr Med Assoc 2011; 101:1-6.
  • 9. Bowling F.L., King L., Paterson J.A., et al. Remote assessment of diabetic foot ulcers using a novel wound imaging system. Wound Repair Regen 2011; 19:25-30.
  • 10. Crouzet J., Lavigne J.P., Richard J.L., Sotto A. Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy. Int J Infect Dis 2011; 15:601-10.
  • 11. Gardner S.E., Hillis S.L., Frantz R.A. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs 2009; 11:119-28.
  • 12. Paul A.G., Ahmad N.W., Lee H.L., et al. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int Wound J 2009; 6:39-46.
  • 13. Sella E.J. Current concepts review: diagnostic imaging of the diabetic foot. Foot Ankle Int 2009; 30:568-76.
  • 14. Vamos E.P., Bottle A., Majeed A., Millett C. Trends in lower extremity amputations in people with and without diabetes in England, 1996-2005. Diabetes Res Clin Pract 2010; 87:275-82.
  • 15. Aragon-Sanchez J., Lipsky B.A., Lazaro-Martinez J.L. Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? Diabet Med 2011; 28:191-4.
  • 16. Lesens O., Desbiez F., Vidal M., et al. Culture of perwound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis. Clin Microbiol Infect 2011; 17:285-91.
  • 17. Morales Lozano R., Gonzalez Fernandez M.L., Martinez Hernandez D., Beneit Montesinos J.V., Guisado Jimenez S., Gonzalez Jurado M.A. Validating the probeto-bone and other tests for diagnosing chronic osteomyelitis in the diabetic foot. Diabetes Care 2010; 33:2140-45.
  • 18. Senneville E., Morant H., Descamps D., et al. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis 2009; 48:888-93.
  • 19. Beckert S., Pietsch A.M., Kuper M., et al. M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds. Ann Surg 2009; 249:677-81.
  • 20. Shakil S., Khan A.U. Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study. Ann Clin Microbiol Antimicrob 2010; 9:2.
  • 21. Yates C., May K., Hale T., et al. Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care 2009; 32:1907-9.
  • 22. Bus S.A., Hazenberg C.E., Klein M., Van Baal J.G. Assessment of foot disease in the home environment of diabetic patients using a new photographic foot imaging device. J Med Eng Technol 2010; 34:43-50.
  • 23. Karthikesalingam A., Holt P.J., Moxey P., Jones K.G., Thompson M.M., Hinchliffe R.J. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med 2010; 27:544-9.
  • 24. Nicolau D.P., Stein G.E. Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics. J Am Podiatr Med Assoc 2010; 100:52-63.
  • 25. Lagace-Wiens P.R., Ormiston D., Nicolle L.E., Hilderman T., Embil J. The diabetic foot clinic: not a significant source for acquisition of methicillin-resistant Staphylococcus aureus. Am J Infect Control 2009; 37:587-9.
  • 26. Sumpio B.E., Armstrong D.G., Lavery L.A., Andros G. The role of interdisciplinary team approach in the management of the diabetic foot: a joint statement from the Society for Vascular Surgery and the American Podiatric Medical Association. J Vasc Surg 2010; 51:1504-6.
  • 27. Storm-Versloot M.N., Vos C.G., Ubbink D.T., Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010; 3:CD006478.
  • 28. Wolcott R.D., Cox S.B., Dowd S.E. Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics. J Wound Care 2010; 19:272-8, 80-1.
  • 29. Wu S.C., Marston W., Armstrong DG. Wound care: the role of advanced wound-healing technologies. J Am Podiatr Med Assoc 2010; 100:385-94.
  • 30. Edwards J., Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010; 4:CD003556.
  • 31. Fitzgerald R.H., Mills J.L., Joseph W., Armstrong D.G. The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage. Eplasty 2009; 9:e15.
  • 32. Sotto A., Richard J.L., Combescure C., et al. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers. Diabetologia 2010; 53:2249-55.
  • 33. Haller N.A., Gil K.M., Gardner W.G., Whittier F.C. Patient computer use to prompt doctor adherence to diabetes management guidelines. J Eval Clin Pract 2009; 15:1118-24.
  • 34. Noel G.J., Strauss R.S., Amsler K., Heep M., Pypstra R., Solomkin J.S. Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by grampositive bacteria. Antimicrob Agents Chemother 2008; 52:37-44.
  • 35. Lavery L.A., Peters E.J., Armstrong D.G., Wendel C.S., Murdoch D.P., Lipsky B.A. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract 2009; 83:347-52.
  • 36. Noel G.J., Bush K., Bagchi P., Ianus J., Strauss R.S. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skinstructure infections. Clin Infect Dis 2008; 46:647-55.
  • 37. Saltoglu N., Dalkiran A., Tetiker T., et al. Piperacillin/ tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clin Microbiol Infect 2010; 16:1252-7.
  • 38. Wang S.H., Sun Z.L., Guo Y.J., et al. Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care IDSA Guideline for Diabetic Foot Infections • CID 2012:54 (15 June) • e167 Downloaded from http://cid.oxfordjournals.org/ at IDSA on May 22, 2012
  • 39. Elamurugan T.P., Jagdish S., Kate V., Chandra Parija S. Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis. Int J Surg 2011; 9:214-6.
  • 40. Nicolau D.P. Diabetic foot infections: a review . J Am Podiatr Med Assoc 2010; 100:52-63.
  • 41. Martinez-Gomez Dde A., Ramirez-Almagro C., CampilloSoto A., Morales-Cuenca G., Pagan-Ortiz J., AguayoAlbasini J.L. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms]. Enferm Infecc Microbiol Clin 2009; 27:317-21.
  • 42. Ramakant P., Verma A.K., Misra R., et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia 2011; 54:58-64.
  • 43. Gregor S., Maegele M., Sauerland S., Krahn J.F., Peinemann F., Lange S. Negative pressure wound therapy: a vacuum of evidence? Arch Surg 2008; 143:189-96.
  • 44. Storm-Versloot M.N., Vos C.G., Ubbink D.T., Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010; 3:CD006478.
  • 45. David M.Z., Glikman D., Crawford S.E., et al. What is communityassociated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197:1235-43.
  • 46. Eleftheriadou I., Tentolouris N., Argiana V., Jude E., Boulton A.J. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010; 70:1785-97.
  • 47. Heiba S.I., Kolker D., Mocherla B. The optimized evaluation of diabetic foot infection by dual isotope SPECT/ CT imaging protocol. J Foot Ankle Surg 2010; 49:529-36.
  • 48. Arbeit R.D., Maki D., Tally F.P., Campanaro E., Eisenstein B.I. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004; 38:1673-81.
  • 49. Chakraborti C., Le C., Yanofsky A. Sensitivity of superficial cultures in lower extremity wounds. J Hosp Med 2010; 5:415-20.
  • 50. Nawaz A., Torigian D.A., Siegelman E.S., Basu S., Chryssikos T., Alavi A. Diagnostic performance of FDGPET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol 2010; 12:335-42.
  • 51. Palestro C.J., Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009; 39:52-65.
  • 52. Barth R.E., Vogely H.C., Hoepelman A.I., Peters E.J. ‘To bead or not to bead?’ Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int J Antimicrob Agents 2011.
  • 53. Bernard L., Uckay I., Vuagnat A., et al. Two consecutive deep sinus tract cultures predict the pathogen of osteomyelitis. Int J Infect Dis 2010; 14:390-3.
  • 54. Fleischer A.E., Didyk A.A., Woods J.B., Burns S.E., Wrobel J.S., Armstrong D.G. Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot. J Foot Ankle Surg 2009; 48:39-46.
  • 55. Weiner R.D., Viselli S.J., Fulkert K.A., Accetta P. Histology versus microbiology for accuracy in identification of osteomyelitis in the diabetic foot. J Foot Ankle Surg 2011; 50:197-200.
  • 56. Nawaz A., Torigian D.A., Siegelman E.S., Basu S., Chryssikos T., Alavi A. Diagnostic performance of FDGPET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol 2010; 12:335-42.
  • 57. Sainsbury D.C. Evaluation of the quality and cost-effectiveness of Versajet hydrosurgery. Int Wound J 2009; 6:24-9.
  • 58. Schintler M.V., Traunmuller F., Metzler J., et al. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. J Antimicrob Chemother 2009; 64:574-8.
  • 59. Traunmuller F., Schintler M.V., Metzler J., et al. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother 2010; 65:1252-7.
  • 60. Marschall J., Bhavan K.P., Olsen M.A., Fraser V.J., Wright N.M., Warren D.K. The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis. Clin Infect Dis 2011; 52:867-72.
  • 61. van Battum P., Schaper N., Prompers L., et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 2011; 28:199-205.
  • 62. Goldman R.J. Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review. PM R 2009; 1:471-89.
  • 63. Lipsky B.A., Berendt A.R. Hyperbaric oxygen therapy for diabetic foot wounds: has hope hurdled hype? Diabetes Care 2010; 33:1143-5.
  • 64. Fincke B.G., Miller D.R., Christiansen C.L., Turpin R.S. Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study. BMC Health Serv Res 2010; 10:193.
  • 65. Griffis C.D., Metcalfe S., Bowling F.L., Boulton A.J., Armstrong DG. The use of gentamycin-impregnated foam in the management of diabetic foot infections: a promising delivery system? Expert Opin Drug Deliv 2009; 6:639-42.
  • 66. Cruciani M., Lipsky B.A., Mengoli C., de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev 2009; 3:CD006810.
  • 67. Gardner S.E., Frantz R.A. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 2008; 10:44-53.
  • 68. Vick-Fragoso R., Hernandez-Oliva G., Cruz-Alcazar J., et al. Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. Infection 2009; 37:407-17.
Просмотров
0 Аннотация
0 PDF
0 Цитирования
Поделились